Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

UBS
Dow
Daiichi Sankyo
Baxter
Fuji
Colorcon
Julphar
Farmers Insurance
AstraZeneca
McKesson

Generated: February 25, 2018

DrugPatentWatch Database Preview

Details for Patent: 4,810,502

« Back to Dashboard

Summary for Patent: 4,810,502
Title: Pseudoephedrine brompheniramine therapy
Abstract:A dosage form is disclosed for delivering the beneficial drugs pseudoephedrine and brompheniramine to a biological environment of use.
Inventor(s): Ayer; Atul D. (Mt. View, CA), Hamel; Lawrence G. (Sunnyvale, CA)
Assignee: ALZA Corporation (Palo Alto, CA)
Application Number:07/019,989
Patent Claim Types:
see list of patent claims
Dosage form; Delivery;

Drugs Protected by US Patent 4,810,502

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 4,810,502

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 602020 ➤ Sign Up
Australia 8093487 ➤ Sign Up
Canada 1297026 ➤ Sign Up
Germany 3769307 ➤ Sign Up
European Patent Office 0281708 ➤ Sign Up
Japan 2538191 ➤ Sign Up
Japan H07215869 ➤ Sign Up
Japan H0729924 ➤ Sign Up
Japan S63243024 ➤ Sign Up
South Korea 950001011 ➤ Sign Up
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Harvard Business School
Julphar
Boehringer Ingelheim
Cerilliant
Cantor Fitzgerald
Chinese Patent Office
McKesson
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot